Homeopathic medicines for heel pai

Phase 3

• Conditions: Health Condition 1: M799- Soft tissue disorder, unspecified

• Registration Number: CTRI/2024/03/064630
• Lead Sponsor: The Calcutta Homoeopathic Medical College and Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 April 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Patients with chronic primary pain of heel (ICD code- 11, MG 30.0). Heel pain persist for at least 3 months or more and absence of any bony deformity of foot on X-ray.

2. Age: 18 – 65years.

3. Patients of either sex including transgenders

4. Patients already undergoing regular oral or topical analgesics or NSAID therapy for painful episodes of chronic primary pain of heel, provided the medications are stopped completely at least 2 weeks prior study entry.

5. Cases eligible for polarity analysis. Patient having at least 5 polar symptoms and 10 indicated remedies under a rubric.

Exclusion Criteria

1. Not providing with informed consent voluntarily

2. Those cases suffering from uncontrolled systemic illness or life-threatening infections, suffering from calcaneal spur or any bony deformity or foot pathology.

3. Self-reported joint disorders (e.g., specific arthropathy, hyperuricaemia and/or gout, fracture or injury to the bones, bone tumour, joint or skin

infections, joint prostheses of the lower limbs, rheumatoid arthritis)

4. Steroid injections within 2 weeks before study entry

5. Recent significant heel surgery within last 6 months

6. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life

7. Pregnancy, puerperium, lactation

8. Vulnerable population – Unconscious, non-ambulatory, too ill for consultation, differently abled, terminally ill or critically ill patients,

mentally disabled people

9. Substance abuse and or dependence

10. Self-reported immune-compromised state

11. Undergoing homoeopathic treatment for any chronic disease within last 6 months, and

12. Simultaneous participation in any other clinical trial

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Foot Function Index (FFI)Timepoint: Every month, up to 3 months

Secondary Outcome Measures

Name	Time	Method
Measure Yourself Medical Outcome Profile (MYMOP-2)Timepoint: Every month, up to 3 months